·Basic Research· Current Issue·  ·Achieve·  ·Search Articles·  ·Online Submission·  ·About IJO·  PMC


Citation: Tian SW, Ren Y, Pei JZ, Ren BC, He Y. Pigment epithelium-derived factor protects retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Int J Ophthalmol  2017; 10(7):1046-1054

 

Pigment epithelium-derived factor protects retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction

 

Shu-Wei Tian1,2, Yuan Ren1, Jin-Zhi Pei1, Bai-Chao Ren2, Yuan He1

 

1Department of Ophthalmology, the Second Affiliated Hospital of Xi’an Medical Univeristy, Xi’an 710038, Shaanxi Province, China

2Department of Ophthalmology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710000, Shaanxi Province, China

Correspondence to: Yuan He. Department of Ophthalmology, the Second Affiliated Hospital of Xi’an Medical Univeristy, Xi’an 710038, Shaanxi Province, China. openji7127@hotmail.com; Bai-Chao Ren. Department of Ophthalmology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710000, Shaanxi Province, China. Dr.renbaichao@gmail.com

Received: 2016-09-30        Accepted: 2017-05-02

 

Abstract

AIM: To investigate the potential of pigment epithelium-derived factor (PEDF) to protect the immortalized rat retinal ganglion cells-5 (RGC-5) exposed to CoCl2-induced chemical hypoxia.

METHODS: After being differentiated with staurosporine (SS), RGC-5 cells were cultured in four conditions: control group cells cultured in Dulbecco 's modified eagle medium (DMEM) supplemented with 10% fetal bovine serum, 100 μmol/mL streptomycin and penicillin (named as normal conditions); hypoxia group cells cultured in DMEM containing 300 μmol/mL CoCl2; cells in the group protected by PEDF were first pretreated with 100 ng/mL PEDF for 2h and then cultured in the same condition as hypoxia group cells; and PEDF group cells that were cultured in the presence of 100 ng/mL PEDF under normal conditions. The cell viability was assessed by MTT assay, the percentage of apoptotic cells was quantified using Annexin V-FITC apoptosis kit, and intra-cellar reactive oxygen species (ROS) was measured by dichloro-dihydro-fluorescein diacetate (DCFH-DA) probe. The mitochondria-mediated apoptosis was also examined to further study the underlying mechanism of the protective effect of PEDF. The opening of mitochondrial permeability transition pores (mPTPs) and membrane potential (Δψm) were tested as cellular adenosine triphosphate (ATP) level and glutathione (GSH). Also, the expression and distribution of Cyt C and apoptosis inducing factor (AIF) were observed.

RESULTS: SS induced differentiation of RGC-5 cells resulting in elongation of their neurites and establishing contacts between outgrowths. Exposure to 300 μmol/mL CoCl2 triggered death of 30% of the total cells in cultures within 24h. At the same time, pretreatment with 100 ng/mL PEDF significantly suppressed the cell death induced by hypoxia (P<0.05). The apoptosis induced by treatment of CoCl2 was that induced cell death accompanied with increasing intra-cellar ROS and decreasing GSH and ATP level. PEDF pre-treatment suppressed these effects (P<0.05). Additionally, PEDF treatment inhibited the opening of mPTPs and suppressed decreasing of Δψm in RGC-5 cells, resulting in blocking of the mitochondrial apoptotic pathway.

CONCLUSION: Pretreatment of RGC-5 cells with 100 ng/mL PEDF significantly decreases the extent of apoptosis. PEDF inhibits the opening of mPTPs and suppresses decreasing of Δψm. Moreover, PEDF also reduces ROS production and inhibits cellular ATP level’s reduction. Cyt C and AIF activation in PEDF-pretreated cultures are also reduced. These results demonstrate the potential for PEDF to protect RGCs against hypoxic damage in vitro by preventing mitochondrial dysfunction.

KEYWORDS: pigment epithelium-derived factor; CoCl2; retinal ganglion cells-5; reactive oxygen species; reduced glutathione hormone; mitochondrial permeability transition pores; membrane potential; adenosine triphosphate; Cyt C; apoptosis-inducing factor

DOI:10.18240/ijo.2017.07.05

 

Citation: Tian SW, Ren Y, Pei JZ, Ren BC, He Y. Pigment epithelium-derived factor protects retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Int J Ophthalmol  2017; 10(7):1046-1054

 

INTRODUCTION

Death of retinal ganglion cell (RGC) is a common feature of many eye diseases, such as glaucoma, retinal ischemia, and optic neuropathy[1]. The RGCs death may involve various mechanisms, for example, reactive oxygen species (ROS), nitric oxide, and excitatory amino acids[2-5]. It has been shown that RGCs die through apoptosis in models of acute optic nerve lesion (axotomy and crush), experimental glaucoma and human glaucoma[6-10].

In humans, visual information entering the eye needs to be processed in the retina before transmitted into visual center in brain via the optic nerve axons[11-12]. The RGCs transfer visual information from the retina to the lateral geniculate nucleus (LGN), and partially to another cortical region, including superior colliculus (SC), coordinating eye movement. Like other neurons in the central nervous system (CNS), RGCs fail to regenerate: once they die, they are lost forever. Thus, glaucoma, as the view of a neurodegenerative disease, ultimately induces irreversible change in neuronal function. Several risk factors have been proposed to contribute to glaucoma progression, including elevated intraocular pressure, age genetic background, thinner corneal thickness and vascular dysregulation[13-19].

RGCs death plays a key role in some ocular pathologies, such as retinal vessel occlusion, diabetic retinopathy and glaucoma. The main cause of irreversible neuronal injury and visual loss is ischemia which is a main trigger of RGCs death and it is accompanied with many progressive changes, such as increase of glutamate excite toxicity and free radical production, decrease of adenosine triphosphate (ATP) stores, ions imbalance, and apoptosis, which eventually lead to RGCs death[20-21]. Importantly, reperfusion following ischemia may potentiate oxidative stress that plays additional role in the RGCs degeneration[22].

Neurotrophins are diffusible trophic molecules that exert a potent survival effect on adult CNS neurons undergoing degeneration induced by variety of intrinsic and extrinsic stimuli. Pigment epithelium-derived factor (PEDF) is a 50 kDa glycoprotein that belongs to the superfamily of serine protease inhibitors, secreted by retinal pigment epithelial (RPE) cells, which was first identified in the conditioned medium of cultured fetal human RPE cells[23]. There are several reviews about PEDF functions in various aspects, such as potent neuroprotective and neurotrophic activities, while its anti-angiogenic effect was confirmed to participate in many aspects of ocular diseases pathogenesis[24]. Several experimental results indicate that after treatment of the ischemic retina with PEDF, the retinal neurons can survive from the damage caused by ischemia. Notably, PEDF shows dramatic effects on the neovascular response that is the feature of retinal ischemia[25-28]. In addition, PEDF acts as a survival factor for a wide range of cultured cells including cerebellar granule cells, hippocampal neurons, and spinal cord motor neurons, protecting these cells against glutamate toxicity and plays the role as an antagonist of apoptosis[29-33]. Nevertheless, only few works about the function of PEDF on protecting the RGCs under hypoxia have been reported. The exact mechanism of its protective action is still need to be revealed.

In the present study, we investigate the neuroprotective potential of PEDF on CoCl2-mimetic hypoxia-induced apoptosis in rat retinal ganglion cells-5 (RGC-5) and explore its possible mechanisms.

Materials and methods

Cell Culture  The transformed retinal ganglion cell line, RGC-5, was received from Zhong Shan Medical Center. The cell line RGC-5 originally derives from postnatal day one rat retinal cells transformed with Ψ2 E1A virus[34]. It was grown in high-glucose Dulbecco’s modified Eagle’s medium (DMEM; Hyclone, USA) containing 10% fetal bovine serum (FBS; Hyclone, USA). RGC-5 cells were cultured in a CO2 incubator (ESPEC, Japan) at 37 with 95% air and 5% CO2. The number of cells would be doubled after 18-20h. We passaged cells at a ratio of 1:4 in every 2d. The passages 10-20 of RGC-5 cells at 80%-90% confluence were used in all experiments. RGC-5 was induced to differentiate into highly branched, no-mitotic cells through the protocol developed by Frassetto et al[35]. Briefly, RGC-5 was firstly cultured as previously described for 24h, then they were seeded into normal growth medium with only 1% FBS (to slow the proliferation rate of the cells) containing staurosporine (SS) 316 nmol/L. After the treatment in this normal growth medium for 24h, the cells were then processed for analysis.

CoCl2-mimetic Hypoxia Injury  CoCl2 was used to cultured cells to cause hypoxia. CoCl2 (Sigma, USA) was dissolved in distilled H2O, and a 0.2-μm filter was used to make the solution sterile. Based on the preliminary study, we pretreated cells with final concentration of 100 ng/mL PEDF in subsequent experiments (PeproTech, USA) for 2h, and then treated them with 300 μmol/L CoCl2 for 24h.

Measurement of Cell Viability  Cells were cultured in 96-well plates with density of 5×103 cells/well and 1% FBS for 24h under various conditions: control group (C), hypoxia damage group (H), PEDF pretreatment group (P+H), and PEDF group (P). Then MTT (5 mg/mL) was added and incubated 4h, after that we used DMSO to dissolve the generated formazan crystals. The absorbance of the crystalline at 490 nm was analyzed with a Tecan Genios (Tecan, Germany). The cell viability of H group, P+H and P groups were represented as the percentage of viable cells relative to cell viability of the control group.

DAPI Staining  DAPI was used to stain RGC-5 cells to visualize fragmented nuclei (Beyotime, China). After being pretreated for 24h, cells were fixed with methanol for 10min following stained with DAPI for 5min at room temperature. Finally, a fluorescence microscope (SIV ZN, Japan) was used to detect RGC-5 cells.

Annexin V-FITC/PI Assay  Annexin V-FITC/PI detection kit (Jiankangyuan, China) was used to detect apoptosis following the manufacturer’s instructions. Briefly, the harvested cells were resuspended in binding buffer with the density of 1×106 cells/mL. Every 1×105 cells were mixed with 5 μL Annexin V-FITC and 10 μL PI. The samples were kept in the dark at room temperature for 15min. Flow cytometry (FACS-400, USA) was used to detect fluorescence. The percentage of apoptosis was expressed with the number of Annexin V(+)/PI(-) cells and the number of Annexin V(+)/PI(+) cells.

Assay for Intracellular Reactive Oxygen Species  Intracellular redox state levels were detected using the fluorescent dye dichloro-dihydro-fluorescein diacetate (DCFH-DA; GENMED, USA). Briefly, we washed cells with phosphate buffered saline (PBS) once and incubated in the PBS containing DCFH-DA for 30min at 37. Intracellular fluorescence was measured by flow cytometry (FACS-400, USA).

Assessment of Total Intracellular Glutathione  The assay is based on that glutathione (GSH) with dinitrothio cyanobenzene (DNTB; NJJC, China) can form a kind of yellow compound. Briefly, after maintaining cell cultures in the presence of different substances for 24h, approximately 1×106 cells were resolved. The cracked cells were added buffer solution and centrifuged at 4000 rpm for 10min. Supernatant samples were transferred to a microplate and added with DNTB, waiting for 5min detected 405 nm absorbance using a Tecan Genios (Tecan, German).

Analysis of Mitochondrial Membrane Potential  Lipophilic and cationic probe, JC-1 (Beyotime, China) was used for the detection of the mitochondrial membrane potential (Δψm) of RGC-5 cells with the fluorescent. Briefly, cells were seeded in 6-well plates, while incubating with JC-1 staining solution (5 μg/mL) for 20min at 37after appropriate treatments. After washing cells twice with JC-1 staining buffer, fluorescence intensity was detected by a flow cytometry (FACS-400, USA). Mitochondrial JC-1 monomers and aggregates respectively showed as green and red. The fluorescence ratio of red to green indirectly reflects the Δψm of RGC-5 cells in different conditions.

Detection of Opened Mitochondrial Permeability Transition Pores  Opened mitochondrial permeability transition pores (mPTPs) of RGC-5 cells was detected by calcein-cobalt, which was included in a mPTP assay kit (GenMed Scientifics Inc., USA). RGC-5 cells were seeded in 6-well plates (2.5×105 cells/well), culturing 24h. After that, cells were treated with various conditions for 24h. Cells were incubated with reagent B and C as ratio 1:50 for 20min at 37, following by washing with reagent A as described in the manufacturer's instruction. After that, cells were washed twice again with reagent A. Finally, the flow cytometry was used to detect fluorescence intensity (FACS-400, USA).

Detection of Cellular Adenosine Triphosphate Levels  We used firefly luciferase based ATP assay kit to measure cellular ATP levels (Beyotime, China). Briefly, we pretreated RGC-5 cells with or without PEDF, followed by 24h treatment of CoCl2. Cells were harvested and centrifuged at 12 000× g for 5min. Every 100 μL ATP detection working dilution was added in 100 μL supernatant, then mixed the components in 24-well plates. Luminance (RLU) represented the protein concentration, which was measured by a Tecan Genios (Tecan, German). Each treatment group was determined by generated standard curves. Total ATP levels were exhibited as μmol/g protein.

Immunofluorescence Analysis  In order to identify RGC-5, cells were cultured in a 6-well plate on coverslips, and then treated with appropriate medium. After cells were 80%-90% confluent fixed with 4% paraformaldehyde, ruptured membrane with Triton X-100, 5% normal goat serum was used for blocking at 37, then after 30min incubated with Thy-1 (Abcam, 1:500), Brn-3C (Sigma, 1:200), GFAP(Abcam, 1:3000), GABA-B (Millipore, 1:3000) and NMDA (Sigma, 1:200) respectively overnight at 4and subsequently incubated with a combination of secondary antibodies goat anti-chicken IgY (Abcam, 1:500) and FITC-anti-rabbit IgG (Kehao, China 1:100) then stained with DAPI 5min. Finally, we examined the coverslips with a fluorescence microscope (SIV ZN, Japan). Assay of expression of Cyt C and apoptosis inducing factor (AIF) were carried on with same method as described above.

Statistical Analysis  All experiments were carried out three times independently. The results were expressed in terms of mean±standard deviation (SD) values, and tested for statistical differences by analysis of variance, using the one-way ANOVA method. When the calculated P value was <0.05, we take the differences are significant.

Results

Pigment Epithelium-derived Factor Decreases Hypoxia-induced Apoptosis of Retinal Ganglion Cells  The purity of RGC-5 cultures was confirmed by detecting expression of Thy-1, Brn-3c, GABA-B receptor and NMDA in the cytoplasm and absence of glial marker GFAP expression (Figure 1).

Shu-Wei Tian1

Figure 1 Cell identity.

 

To prove the protective functions of PEDF on RGC-5 cells under the condition of hypoxia, morphological changes of various treated RGC-5 cells were analyzed. In control group, RGC-5 cells cultured in normal condition without any treatment exhibited morphological characters of mature ganglion cells with long extensions. In the hypoxia group, with prolonged exposure time, increased cells were observed rounded up (Figure 2). MTT assays were used to quantitate cell viability. The viability of RGC-5 cells decreased to 69%±1.5% after hypoxic exposure 24h, while pretreated RGC-5

cells with PEDF exhibited higher level of cell viability to 86%±3% (P<0.05 vs H group). Notably, the viability of RGC-5 cells in C group and P+H group exhibited no significant differences (Figure 3). We used DAPI-staining to determine nuclear changes under various conditions of RGC-5 cells. RGC-5 cells exposed to hypoxic condition expressed clear changes in chromatin morphology, as condensation and fragmentation, exhibiting bright blue labeling, and the changes were weakened by PEDF (Figure 4).

Shu-Wei Tian2

Figure 2 Phase-contrast micrographs of RGC-5 cells  RGC-5 cells were differentiated by staurosporine following exposed to hypoxia for 24h in different groups. C: Control group; H: Hypoxia group; P+H: PEDF pretreated group; P: PEDF group.

Shu-Wei Tian3

Figure 3 MTT assay  Cell viability of RGC-5 cells exposed to hypoxia for 24h in different group, measured by MTT assay (aP<0.05 as compared to the C group; cP<0.05 as compared to the H group).

Shu-Wei Tian4

Figure 4 DAPI staining  Photomicrographs of RGC-5 cells nuclear stained with DAPI (in different conditions).

 

Annexin V-FITC/PI assay was also used for further analysis of the anti-apoptotic effects of PEDF (Figure 5). Our data support the previous finding showed that CoCl2 induce apoptosis of RGC-5 cells. The percentage of apoptotic cells after 24h was significantly increased after CoCl2 treatment (34.82%±2.17% vs 4.39%±1.23%, P<0.05). However, pretreatment of these cells with PEDF decreased this number significantly (12.46%±0.31%, P<0.05). It is thus clear that PEDF suppressed apoptosis of RGC-5 cells, which induced by hypoxia.

Shu-Wei Tian5

Figure 5 Annexin V-FITC/PI staining  Apoptotic cells were counted as percentage via staining by Annexin V-FITC/PI and analyzed with flow cytometry. The area of Annexin V(+)/PI(−) and Annexin V(+)/PI(+) were included in apoptotic cells.

 

Hypoxia Induced the Elevation of Intracellular Reactive Oxygen Species  Increased intracellular ROS in cells and tissues is a cause of damage in many pathophysiological conditions. Plenty of work have documented that hypoxia could induce the elevation of intracellular ROS[36]. In our study, we examined the role of ROS in the death of RGC-5 cells. Consistent with earlier studies, an increasing level of ROS was observed in RGC-5 cells exposed to hypoxic stress, 477.27±53.87 (P<0.05). However, PEDF suppressed hypoxia-induced ROS increase in RGC-5 cells (190.18±13.31, P<0.05) (Figure 6).

Shu-Wei Tian6

Figure 6 Intracellular ROS  The effect of PEDF on the ROS production in RGC-5 cells exposed to hypoxia. ROS was measured using DCFH-DA cultures exposed to normoxia or hypoxia for 24h under the condition with or without PEDF. Results are expressed as the means±SD. aP<0.05 compared to the C group; cP<0.05 compared to the H group.

 

We carried out experiments to measure the level of cellular total anti-oxidant GSH to further evaluate the effect of hypoxia on RGC-5 cells. As shown in Figure 7, hypoxia decreased the GSH from 45.97±17.26 to 10.63±5.33 (P<0.05). When the RGC-5 cells were pretreated with PEDF before the application of hypoxia, no significant decrease of GSH was observed. There were no significant differences between PEDF group and control group, indicating that the cellular redox status is deteriorated when cells are exposed to the hypoxia, and PEDF protects RGC-5 cells from it.

Shu-Wei Tian7

Figure 7 Intracellular GSH  The effect of PEDF on the intracellular GSH in RGC-5 cells exposed to hypoxia. Cells culture exposed to normoxia or hypoxia for 24h in the presence or absence of PEDF. Results are expressed as the means±SD. aP<0.05 compared to the C group; cP <0.05 compared to the H group.

 

Pigment Epithelium-derived Factor Inhibits the Opening of Mitochondrial Permeability Transition Pores  Elevated Ca2+ level triggers the opening of mPTPs during hypoxia, then initiated mPTP furthermore induces to mitochondrial dysfunction[37]. Therefore, distribution of green fluorescence, which emitted from calcein, was monitored by the calcein-cobalt method as a result of intact mPTPs to examine the influence of PEDF on mPTPs. After 24h induction of hypoxia, significantly higher level of the opening of mPTPs in PEDF-treated cultures was observed in fluorescence measurement (Figure 8), with the ratio of M2/M1 changing from (0.47±0.17, P<0.05) in H group to (5.87±2.34) in H+P group. Our results thus clearly demonstrated the ability of PEDF on reducing the extent of opened mPTPs in hypoxic condition.

Shu-Wei Tian8

Figure 8 Opening of mPTPs  The normalized relative fluorescence units (NRFU) of calcein exhibit the opening of mPTPs. RGC-5 cells were pretreated with or without PEDF and exposed to normoxia or hypoxia for 24h. Results exhibit as the means±SD. aP<0.05 compared to the C group, cP<0.05 compared to the H group.

 

Pigment Epithelium-derived Factor Prevents Mitochondrial Dysfunction  Δψm and level of cellular ATP indicate mitochondrial activity. Therefore, we further investigated the effects of PEDF on mitochondrial function based on the above parameters. After 24h hypoxic exposure, RGC-5 cells exhibited lower Δψm values (P<0.05). However, the Δψm of PEDF-treated cells and normal cells showed no marked difference (Figure 9). Except the above index, cellular ATP level also exhibits mitochondrial function. In this study, after 24h treatment of hypoxia, cellular ATP level drastically decreased to 0.51±0.03 μmol/g protein as Figure 10 shows. In contrast, pretreatment of cultured RGC-5 cells with PEDF still contains relatively high cellular ATP content of 0.81±0.01 μmol/g protein (P<0.05). There were no marked differences between P group and C group (Figure 10). Thus these findings directly demonstrated that PEDF has the effect of protecting mitochondrial function during hypoxia.

Shu-Wei Tian9

Figure 9 Mitochondria Δψm  Mitochondrial Δψm of RGC-5 cells were determined using JC-1. RGC-5 cells were exposed to normoxia or hypoxia for 24h in the condition with or without PEDF. Results show as the mean±SD. aP<0.05 compared to the C group; cP<0.05 compared to the H group.

Shu-Wei Tian10

Figure 10 Cellular ATP  Cellular ATP concentration of RGC-5 cells were detected after exposed to normoxia or hypoxia 24h cultured with or without PEDF. Results are expressed as the mean±SD. aP<0.05 compared to the C group; cP <0.05 compared to the H group.

 

Pigment Epithelium-derived Factor Affects Cyt C Involved Mitochondrial Apoptotic Pathway  Cyt C entering to the cytoplasm mediates mitochondrial activation of apoptosis. Importantly, we also observed a statistically significant difference between the expression of Cyt C in the hypoxia group and the control group. During the process of apoptosis, Cyt C dispersed while its concentration in cytosol increased. The increase of red fluorescence in PEDF pretreated group is lower, which indicates PEDF inhibits Cyt C releasing to cytoplasm from mitochondria (Figure 11).

Shu-Wei Tian11

Figure 11 Expression and distribution of Cyt C  Effects of PEDF on the expression and distribution of Cyt C in RGC-5 cells exposed to hypoxia for 24h. Cyt C immunoreactivity showed red in RGC-5 with nuclear counter stained with DAPI (blue).

 

Pigment Epithelium-derived Factor Affects Apoptosis Inducing Factor Apoptotic Pathway  We also found difference between the expression of AIF in H group compared with C group, and results showed that AIF dispersed in nucleus while its concentration increased in cytosol. Weaker red fluorescent labeling in cytoplasm was observed in PEDF group, which suggests that PEDF inhibits the release of AIF (Figure 12).

Shu-Wei Tian12

Figure 12 Expression and distribution of AIF  Effects of PEDF on the expression and distribution of AIF in RGC-5 exposed to hypoxia for 24h. The bright red fluorescence indicates IF immunoreactivity (red) in RGC-5 cells.

 

Discussion

We used the RGC-5 cell line to elucidate that PEDF can suppress hypoxia-induced apoptosis in RGCs with the focus on mitochondrial function. Many endogenous trophic factors have protective functions in models of neurodegenerative diseases. Among them, PEDF is a cell survival factor secreted by the RPE and widely expresses in most regions of nervous system[38-39]. The cytoprotective effects of PEDF have previously been observed in cerebellar granule cells and retinal pericytes[40]. Reduced extracellular concentration of PEDF leads to neuronal damage due to various cell-damaging conditions including hypoxia[41]. In our hypoxia model, PEDF preserved cells from damage. We used 100 ng/mL PEDF on RGC-5 and found the total number of apoptotic cells decreased from about 30% by 15%, meaning that PEDF obviously provides neuroprotective effect. Furthermore, we used reliable methods to identify apoptosis and viability of cells, including the Annexin V-FITC/PI assays to detect apoptosis. Annexin V-FITC/PI assay showed that percentage of apoptotic cells was 34.82%±2.17% vs 12.46%±0.31% (P<0.05) in C group and P group respectively. The MTT assays also provided strong evidence for cell viability to support our hypothesis that PEDF plays an important role in neuroprotective effects on RGCs.

CoCl2 is a common agent to induce hypoxia is shown by the previous studies[42-43], and in our work using RGC-5, we prove that CoCl2 contributes to hypoxia-induced damage. Gene and protein expression are influenced by CoCl2 simulated hypoxia, which is similar to ischemia[44]. CoCl2 induced hypoxia breaks the balance of hypoxia-inducible factor-1 (HIF-1), between the degradation and the consequent accumulation, thereby expression of heat shock protein-27 increases[45]. Moreover, in CoCl2-treated RGC-5 accumulation of HIF-1 protein also induces generation of β-amyloid peptide. In addition, CoCl2 could active caspase-3/8, produce ROS and fission anti-apoptotic protein Mcl-1 to induce apoptosis as shown various  in vitro studies[46-47]. And both in vivo and in vitro studies show that RGCs are sensitive to oxidative stress especially in pathological situations. In the experimental studies, CoCl2 is used in the hypoxia model and there are a lot of works providing evidences that CoCl2 induces apoptosis while damaging retinal photoreceptor[48-49].

ROS plays an important role in retinal cells injury through changing cellular redox potentials while reducing ATP levels, which indirectly induce apoptosis with depleted GSH in diabetic retinopathy and glaucoma[50-52]. The imbalance between oxidative product and anti-oxidants results in dysfunction and destruction of cells, and further leads to tissue injury. Plenty of studies demonstrate that PEDF has a beneficial aspect in protecting retinal endothelial cell from the increased ROS induced by high glucose levels. In our study, we first describe the similar protective function is also effective on RGC-5. CoCl2 significantly stimulates the ROS activation (477.27±53.87), while pretreatment with PEDF could prevent the ROS increasing (190.18±13.31, P<0.05). Here we evaluate the possible connection between PEDF and mitochondria function. It is well known that mitochondria is a key component for cells including RGCs. Mitochondrial dysfunction plays an important role in hypoxia-induced apoptosis in RGCs. Mitochondrial permeability transition is a critical factor in mediating mitochondrial dysfunction. Morphological disintegration and functional damage of mitochondria occur when the cell death is initiated[53]. From our current research, we provide further evidence that the anti-apoptotic function of PEDF prevents mitochondrial dysfunction by suppressing the mitochondrial permeability transition and obstructing the Cyt C apoptotic pathway. During hypoxia, oxygen rapidly depletes then ATP levels decrease, thus induce ionic gradients in cells are imbalance which lead to subsequent neuronal depolarization. Mitochondrial permeability transition pores are non-specific pores that connect the internal and outer membranes of mitochondria. The molecule diameter up to about 1500 Da is allowed to cross the mitochondrial membrane. Under the hypoxia situation, enormous amounts of Ca2+ flow into cells, while adenine nucleotide depletes and cellular ROS levels elevate. These trigger the opening of mPTPs, furthermore, mitochondrial permeability transition occurs. Our observation that PEDF could suppress the opening of mPTPs (5.87±2.34 vs 0.47±0.17, P<0.05) proves the protective role of PEDF in the regulation of mPTPs.

Occurrence of the mitochondrial permeability transition in a cell induces a series of danger which directly threaten its survival, including bioenergetic, biosynthetic, and redox[9,54]. The mitochondrial inner membrane is permeable to protons when the mitochondrial permeability transition happens, uncoupling of the electron respiratory chain occurs which results in the destruction of membrane potential, furthermore induces stop generation of mitochondrial ATP[55]. The hypoxia-induced injury of mitochondrial Δψm and declined ATP level is relieved on RGC-5, which are pretreated by PEDF. Our study supports neuroprotection effect of PEDF in the view of preventing mitochondrial dysfunction. The results exhibit in this study also is consistent with previous studies of cerebella granular cells exposed to glutamate. PEDF were demonstrated has the capability in strengthening the mitochondrial activity of cells[56].

Another threatening consequence of altered mitochondrial permeability is the apoptotic proteins release from the mitochondria into the cytosol[53-55]. Because of Cyt C is a critical component of the electron transfer chain, mitochondrial function is damaged when the mitochondrial permeability transition is triggered and Cyt C releases from the mitochondria into the cytosol. In this research, comparing to the cells cultured in hypoxia medium, there is relatively lower cytosolic Cyt C level in PEDF-pretreated cultures, thus proves that there is correlation between PEDF and the protection of mitochondrial function. Furthermore, once Cyt C enters the cytosol, apoptotic peptidase activating factor 1 (Apaf-1) and dATP are activated to assemble an apoptosome. Moreover, apoptosome collects and activates procaspase-9, which further leads to activation of other downstream caspase to launch apoptosis[55].

AIF causes nuclear chromatin condensation and further affects mitochondria, leading to a drop in the ∆ψm and triggering the release of Cyt C as shown by immunofluorescence staining[57-59]. Moreover, the translocation of AIF occurs in the process of cell death in vivo, in models of retinal degeneration. AIF releasing from mitochondria appears to universally associate with cell death. Here we showed elevation of AIF in the RGC-5 in the hypoxic condition and its decrease following protection with PEDF.

Although the underlying mechanisms are not very clear and require further study, the data from our study clearly demonstrate that PEDF plays an important role in preventing signaling pathways of apoptosis.

In conclusion, our study provides evidence that PEDF can protect RGC-5 from hypoxia-induced mitochondrial dysfunction while inhibiting apoptosis. Its effects include inhibiting the opening of mPTPs and suppressing the decrease of Δψm. Moreover, PEDF also reduces ROS production and inhibited cellular ATP level’s reduction which are important index of mitochondrial dysfunction. And the research elucidates PEDF has an effect on inhibiting release of apoptogenic protein. At the same time, PEDF, as a neurotrophins to be new treatment, still requires further in vivo studies to ensure the efficiency of therapy in protecting functions on RGCs. PEDF as a highly attractive treatment application in the ophthalmic clinic, the long-term effects in retinal diseases have to be investigated.

ACKNOWLEDGEMENTS

Foundation: Supported by National Natural Science Foundation of China (No.81100665).

Conflicts of Interest: Tian SW, None; Ren Y, None; Pei JZ, None; Ren BC, None; He Y, None.

References

1 Kawasaki A, Kardon RH. Disorders of the pupil. Ophthalmol Clin North Am 2001;14(1):149-168. [PubMed]

2 Li SY, Fu ZJ, Lo AC. Hypoxia-induced oxidative stress in ischemic retinopathy. Oxid Med Cell Longev 2012;2012:426769.

3 Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 2012;31(2):152-181. [CrossRef] [PubMed]

4 Qu J, Wang D, Grosskreutz CL. Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res 2010;91(1):48-53. [CrossRef] [PMC free article] [PubMed]

5 Chang EE, Goldberg JL. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 2012; 119(5):979-986. [CrossRef] [PMC free article] [PubMed]

6 Galindo-Romero C, Aviles-Trigueros M, Jimenez-Lopez M, Valiente-Soriano FJ, Salinas-Navarro M, Nadal-Nicolas F, Villegas-Perez MP, Vidal-Sanz M, Agudo-Barriuso M. Axotomy-induced retinal ganglion cell death in adult mice: quantitative and topographic time course analyses. Exp Eye Res 2011;92(5):377-387. [CrossRef] [PubMed]

7 Kalesnykas G, Oglesby EN, Zack DJ, Cone FE, Steinhart MR, Tian J, Pease ME, Quigley HA. Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma. Invest Ophthalmol Vis Sci 2012; 53(7):3847-3857. [CrossRef] [PMC free article] [PubMed]

8 Doh SH, Kim JH, Lee KM, Park HY, Park CK. Retinal ganglion cell death induced by endoplasmic reticulum stress in a chronic glaucoma model. Brain Res  2010;1308:158-166. [CrossRef] [PubMed]

9 Gemenetzi M, Yang Y, Lotery AJ. Current concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatment. Eye (Lond) 2012;26(3):355-369. [CrossRef] [PMC free article] [PubMed]

10 Baltmr A, Duggan J, Nizari S, Salt TE, Cordeiro MF. Neuroprotection in glaucoma-Is there a future role? Experimental Eye Research 2010; 91(5):554-566. [CrossRef] [PubMed]

11 Lyon DC, Nassi JJ, Callaway EM. A disynaptic relay from superior colliculus to dorsal stream visual cortex in macaque monkey. Neuron 2010;65(2):270-279. [CrossRef] [PMC free article] [PubMed]

12 Dhande OS, Huberman AD. Retinal ganglion cell maps in the brain: implications for visual processing. Curr Opin Neurobiol 2014;24(1):133-142. [CrossRef] [PMC free article] [PubMed]

13 The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000;130(4):429-440. [CrossRef]

14 Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120(6):714-720; discussion 829-830. [CrossRef] [PubMed]

15 Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z, Group E. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114(11):1965-1972. [CrossRef] [PubMed]

16 Leske MC, Connell AM, Wu SY, Nemesure B, Li X, Schachat A, Hennis A. Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. Arch Ophthalmol 2001;119(1):89-95. [PubMed]

17 Mukesh BN, McCarty CA, Rait JL, Taylor HR. Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 2002;109(6):1047-1051. [CrossRef]

18 Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 2003; 136(5):805-813. [CrossRef]

19 Leske MC. Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings. Curr Opin Ophthalmol 2009;20(2):73-78. [CrossRef] [PMC free article] [PubMed]

20 Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004;23(1):91-147. [CrossRef] [PubMed]

21 Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006;25(5):490-513. [CrossRef] [PMC free article] [PubMed]

22 Nakajima Y, Inokuchi Y, Nishi M, Shimazawa M, Otsubo K, Hara H. Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res 2008;1226:226-233. [CrossRef] [PubMed]

23 Becerra SP, Dass CR, Yabe T, Crawford SE. Pigment epithelium-derived factor: chemistry, structure, biology, and applications. J Biomed Biotechnol 2012;2012:830975. [CrossRef] [PMC free article] [PubMed]

24 Bouck N. PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med 2002;8(7):330-334. [CrossRef]

25 Ogata N, Wang L, Jo N, Tombran-Tink J, Takahashi K, Mrazek D, Matsumura M. Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr Eye Res 2001;22(4):245-252. [CrossRef]

26 Stellmach V, Crawford SE, Zhou W, Bouck N. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 2001;98(5):2593-2597. [CrossRef] [PMC free article] [PubMed]

27 Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 2002;43(3):821-829. [PubMed]

28 Takita H, Yoneya S, Gehlbach PL, Duh EJ, Wei LL, Mori K. Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003;44(10):4497-4504. [CrossRef]

29 Liu JT, Chen YL, Chen WC, Chen HY, Lin YW, Wang SH, Man KM, Wan HM, Yin WH, Liu PL, Chen YH. Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol 2012;2012:871272.

30 Barnstable CJ, Tombran-Tink J. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog Retin Eye Res 2004;23(5):561-577. [CrossRef] [PubMed]

31 Amaral J, Becerra SP. Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization. Invest Ophthalmol Vis Sci 2010;51(3):1318-1326. [CrossRef] [PMC free article] [PubMed]

32 Sanagi T, Yabe T, Yamada H. Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxicity. J Neuropathol Exp Neurol 2010;69(3):224-233. [CrossRef] [PubMed]

33 Bilak MM, Becerra SP, Vincent AM, Moss BH, Aymerich MS, Kuncl RW. Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J Neurosci 2002;22(21):9378-9386. [PubMed]

34 Krishnamoorthy RR, Agarwal P, Prasanna G, Vopat K, Lambert W, Sheedlo HJ, Pang IH, Shade D, Wordinger RJ, Yorio T, Clark AF, Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res 2001;86(1-2):1-12. [CrossRef]

35 Frassetto LJ, Schlieve CR, Lieven CJ, Utter AA, Jones MV, Agarwal N, Levin LA. Kinase-dependent differentiation of a retinal ganglion cell precursor. Invest Ophthalmol Vis Sci 2006;47(1):427-438. [CrossRef] [PubMed]

36 Guo M, Song LP, Jiang Y, Liu W, Yu Y, Chen GQ. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms. Apoptosis 2006; 11(1):67-77. [CrossRef] [PubMed]

37 Zoratti M, Szabo I, De Marchi U. Mitochondrial permeability transitions: how many doors to the house? Biochim Biophys Acta 2005;1706(1-2):40-52. [CrossRef] [PubMed]

38 Marciniak K, Butwicka A, Nowak JZ. PEDF: an endogenous factor displaying potent neuroprotective, neurotrophic, and antiangiogenic activity. Postepy Hig Med Dosw (Online) 2006;60:387-396.

39 Sheikpranbabu S, Haribalaganesh R, Gurunathan S. Pigment epithelium- derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes. Diabetes Metab 2011;37(6):505-511. [CrossRef]

40 Yabe T, Wilson D, Schwartz JP. NFkappaB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J Biol Chem 2001;276(46):43313-43319. [CrossRef] [PubMed]

41 Unterlauft JD, Eichler W, Kuhne K, Yang XM, Yafai Y, Wiedemann P, Reichenbach A, Claudepierre T. Pigment epithelium-derived factor released by Muller glial cells exerts neuroprotective effects on retinal ganglion cells. Neurochem Res 2012;37(7):1524-1533. [CrossRef] [PMC free article] [PubMed]

42 Zhu X, Zhou W, Cui Y, Zhu L, Li J, Feng X, Shao B, Qi H, Zheng J, Wang H, Chen H. Pilocarpine protects cobalt chloride-induced apoptosis of RGC-5 cells: involvement of muscarinic receptors and HIF-1 alpha pathway. Cell Mol Neurobiol 2010;30(3):427-435. [CrossRef] [PubMed]

43 Tsui L, Fong TH, Wang IJ. YC-1 targeting of hypoxia-inducible factor-1alpha reduces RGC-5 cell viability and inhibits cell proliferation. Mol Vis 2012;18:1594-1603. [PMC free article] [PubMed]

44 Caltana L, Merelli A, Lazarowski A, Brusco A. Neuronal and glial alterations due to focal cortical hypoxia induced by direct cobalt chloride (CoCl2) brain injection. Neurotox Res 2009;15(4):348-358. [CrossRef] [PubMed]

45 Yang SJ, Pyen J, Lee I, Lee H, Kim Y, Kim T. Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells. J Biochem Mol Biol 2004;37(4):480-486. [CrossRef]

46 Merelli A, Caltana L, Girimonti P, Ramos AJ, Lazarowski A, Brusco A. Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats. Neurotox Res 2011;20(2):182-192. [CrossRef] [PubMed]

47 Hara A, Niwa M, Aoki H, Kumada M, Kunisada T, Oyama T, Yamamoto T, Kozawa O, Mori H. A new model of retinal photoreceptor cell degeneration induced by a chemical hypoxia-mimicking agent, cobalt chloride. Brain Res 2006;1109(1):192-200. [CrossRef] [PubMed]

48 Whitlock NA, Agarwal N, Ma JX, Crosson CE. Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci 2005;46(3):1092-1098. [CrossRef] [PubMed]

49 Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414(6865):813-820. [CrossRef] [PubMed]

50 Hancock JT, Desikan R, Neill SJ. Does the redox status of cytochrome C act as a fail-safe mechanism in the regulation of programmed cell death? Free Radic Biol Med 2001;31(5):697-703. [CrossRef]

51 West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000;17(3):171-180. [CrossRef]

52 Kristian T. Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium 2004;36(3-4):221-233. [CrossRef] [PubMed]

53 Armstrong JS. The role of the mitochondrial permeability transition in cell death. Mitochondrion 2006;6(5):225-234. [CrossRef] [PubMed]

54 Galluzzi L, Morselli E, Kepp O, Kroemer G. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochim Biophys Acta 2009; 1787(5):402-413. [CrossRef] [PubMed]

55 El Idrissi A. Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 2008;34(2):321-328. [CrossRef] [PubMed]

56 Loeffler M, Daugas E, Susin SA, Zamzami N, Metivier D, Nieminen AL, Brothers G, Penninger JM, Kroemer G. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J 2001;15(3):758-767. [CrossRef] [PubMed]

57 Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC, Kroemer G. Two distinct pathways leading to nuclear apoptosis. J Exp Med 2000;192(4):571-580. [CrossRef]

58 Ferri KF, Jacotot E, Blanco J, Este JA, Zamzami N, Susin SA, Xie Z, Brothers G, Reed JC, Penninger JM, Kroemer G. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med 2000;192(8):1081-1092. [CrossRef]

59 Norberg E, Orrenius S, Zhivotovsky B. Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF). Biochem Biophys Res Commun 2010;396(1):95-100. [CrossRef] [PubMed]